Survivin: A novel marker and potential therapeutic target for human angiosarcoma.

about

Cutaneous angiosarcoma: update on biology and latest treatment.

P2860

Q47807442-A26B4ECC-9113-4592-A5E8-E3EE32B43D5C

P2860

Survivin: A novel marker and potential therapeutic target for human angiosarcoma.

Item

http://www.wikidata.org/entity/Q47134049

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Survivin: A novel marker and potential therapeutic target for human angiosarcoma.

@en

Survivin: A novel marker and potential therapeutic target for human angiosarcoma.

@nl

type

Item

label

Survivin: A novel marker and potential therapeutic target for human angiosarcoma.

@en

Survivin: A novel marker and potential therapeutic target for human angiosarcoma.

@nl

prefLabel

Survivin: A novel marker and potential therapeutic target for human angiosarcoma.

@en

Survivin: A novel marker and potential therapeutic target for human angiosarcoma.

@nl

P1476

Survivin: A novel marker and potential therapeutic target for human angiosarcoma

@en

P2093

Akihiko Yoshida

http://www.w3.org/2001/XMLSchema#string

Akira Kawai

http://www.w3.org/2001/XMLSchema#string

Aoi Ohira

http://www.w3.org/2001/XMLSchema#string

Hirokazu Chuman

http://www.w3.org/2001/XMLSchema#string

Kayo Kuyama

http://www.w3.org/2001/XMLSchema#string

Kenzo Takahashi

http://www.w3.org/2001/XMLSchema#string

Mikio Masuzawa

http://www.w3.org/2001/XMLSchema#string

Taisuke Mori

http://www.w3.org/2001/XMLSchema#string

Takao Kinjo

http://www.w3.org/2001/XMLSchema#string

Takuya Miyagi

http://www.w3.org/2001/XMLSchema#string

P2860

Control of apoptosis and mitotic spindle checkpoint by survivin

Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies

YAP and TAZ: a nexus for Hippo signaling and beyond

Essential role for survivin in early brain development

Recurrent PTPRB and PLCG1 mutations in angiosarcoma.

Adhesion molecule-mediated hippo pathway modulates hemangioendothelioma cell behavior

Hippo signaling: growth control and beyond.

Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.

MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.

A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma

P304

2295-2305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13379

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Hirofumi Arakawa

Masayuki Tsuneki

Naoya Yamazaki

P577

2017-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28845553

http://www.w3.org/2001/XMLSchema#string

P932

5665764

http://www.w3.org/2001/XMLSchema#string

Survivin: A novel marker and potential therapeutic target for human angiosarcoma.

about

P2860

P2860

Survivin: A novel marker and potential therapeutic target for human angiosarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932